Thyroid cancer review 3: management of medullary and undifferentiated thyroid cancer
- 25 November 2005
- journal article
- review article
- Published by Hindawi Limited in International Journal Of Clinical Practice
- Vol. 60 (1) , 80-84
Abstract
This is the last of the three review articles dealing with thyroid cancer. Over 90% of thyroid cancer is of the differentiated type associated with a very good 10-year disease-free survival rate. In contrast, the rare forms of thyroid cancer which comprise medullary thyroid cancer arising from parafollicluar C cells, Hurthle cell carcinoma, anaplastic carcinoma, thyroid lymphoma and squamous cell carcinoma are typically associated with a poorer survival rate. Management is based upon small retrospective cohort studies.Keywords
This publication has 31 references indexed in Scilit:
- Molecular pathogenesis of thyroid cancerSurgical Oncology, 2003
- Medullary Thyroid Carcinoma and Multiple Endocrine Neoplasia Type 2Endocrine Pathology, 2003
- The TNM system: Our language for cancer careJournal of Surgical Oncology, 2002
- Current Approaches to Primary Therapy for Papillary and Follicular Thyroid CancerThe Journal of Clinical Endocrinology & Metabolism, 2001
- Preoperative Calcitonin Levels Are Predictive of Tumor Size and Postoperative Calcitonin Normalization in Medullary Thyroid CarcinomaThe Journal of Clinical Endocrinology & Metabolism, 2000
- A National Cancer Data Base report on 53,856 cases of thyroid carcinoma treated in the U.S., 1985-1995Cancer, 1998
- Multiple endocrine neoplasiaCurrent Opinion in Oncology, 1991
- Multiple endocrine neoplasiaCurrent Opinion in Oncology, 1990
- Distant Metastases in Differentiated Thyroid Carcinoma: A Multivariate Analysis of Prognostic Variables*The Journal of Clinical Endocrinology & Metabolism, 1988
- Medullary thyroid carcinoma: role of high-resolution US.Radiology, 1987